Exchange Income Corporation ( EIF:CA) Q4 2025 Earnings Call February 25, 2026 8:30 AM EST ...

Equillium (EQ) remains a 'Hold' as it advances EQ504 for ulcerative colitis, with phase 1 trial initiation targeted for mid-2026. Company's Multi-Cytokine Platform enables selective cytokine targeting ...

Propranolol is a prescription beta-blocker that has been on the market for decades and is now widely available as a generic.

Highly pathogenic avian influenza (HPAI) continues to impact commercial poultry facilities in Pennsylvania, prompting state and federal officials to expand response and surveillance efforts.

A proposed function of TADs is to contribute to gene regulation by promoting chromatin interactions within a TAD and by suppressing interactions between TADs. Here, we directly probe the ...

Updated ACVIM guidance prioritizes therapeutic diets and microbiome-directed therapy, identifying Visbiome Vet as the only probiotic currently backed by randomized clinical trial data for CIE.

Full-year revenue of EUR 6,466.4 million, up 6.5% organically (with 6.3% organic growth in Q4). At constant currency, the growth was up 7.3% year-on-year and up 3.6% on a reported basis, › Adjusted ...

Gunnison Copper Corp. (TSX: GCU) (OTCQB: GCUMF) (FSE: 3XS0) ("Gunnison" or the "Company") is pleased to announce the results of an updated NI ...

February 25, 2026) - Gunnison Copper Corp. (TSX: GCU) (OTCQB: GCUMF) (FSE: 3XS0) ("Gunnison" or the "Company") is pleased to ...

Alkane Resources Limited (ASX: ALK; TSX: ALK; OTCQX: ALKRY) (‘Alkane’ or ‘the Company’) is pleased to announce the latest exploration results for ...